Lenacapavir Access Under Scrutiny by Health Advocates
Explore the urgent call for lenacapavir access, as advocates seek equitable HIV prevention for all communities worldwide.
UNAIDS Closure Causes Outrage Among Health Advocates
Activists warn that the UNAIDS closure will critically affect HIV/AIDS progress, calling for urgent global health action.
Generic HIV Prevention Drug to Cost Just $40 Annually from 2027
Explore the benefits of the generic HIV prevention drug lenacapavir, set to change the landscape of global health by 2027.
America First Health Policy Threatens Global Health Aid
The future of US health aid is uncertain. Find out how the America First health policy threatens HIV/Aids support in South Africa.
End of UNAIDS Looms as UN Proposes Agency Closure by 2026
Explore the implications of the end of UNAIDS by 2026 amid a funding crisis in the global HIV/AIDS response.
HIV Prevention Injection Changes the Game in Treatment
Discover the new HIV prevention injection coming to South Africa. Learn how lenacapavir offers a game-changing alternative to daily pills.
Rare Fungal Infection Poses New Threat in South Africa
A new case of a rare fungal infection in Bloemfontein highlights a dangerous health threat to immunocompromised individuals.
HIV Prevention Injection Changes the Game in Treatment
Discover the new HIV prevention injection coming to South Africa. Learn how lenacapavir offers a game-changing alternative to daily pills.
Sakeliga’s NHI Legal Battle for Constiutional Justice
Learn about Sakeliga's NHI legal battle as they challenge the constitutionality of South Africa's National Health Insurance plan.
Lenacapavir for HIV Prevention in South Africa
South Africa will introduce lenacapavir for HIV prevention in 2026, offering a new hope in the fight against HIV.